Winston Pharmaceuticals IncOver The Counter Market:WPHM
- LAST PRICE0.0000
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close--- / 0.0000
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Winston Pharmaceuticals Inc | 80.0 | 0.0x | --- |
Veritas Farms Inc | 160.0 | 0.0x | --- |
Marijuana Company Of America Inc | 22.1K | 0.0x | --- |
Aaron Sparks Industries Inc | 410.0 | 0.0x | --- |
Nutralife Biosciences Inc | 17.7K | 0.0x | --- |
Optigenex Inc | 120.0 | --- | --- |
Company Information
Winston Pharmaceuticals, Inc. is a specialty pharmaceutical company. The Company discovers, develops and commercializes therapeutics for managing and alleviating pain. The Company's late stage candidates include products for the treatment of episodic cluster headache, chronic migraine headache, osteoarthritis, rheumatoid arthritis, neuropathic pain, and pain and inflammation in inflammatory bowel disease. The Company is developing Civamide, which is a transient receptor potential channels vanilloid-1 (TRPV-1) modulator in different dosage forms for several different pain indications. The Company's other products are under development for the treatment of headache and neuropathic and rheumatological pain.
Contact Information
- Headquarters
- 100 N. Fairway Drive,, Suite 134VERNON HILLS, IL, United States 60061
- Phone
- 847-362-8200
- Fax
- 847-362-8394
Executives
- Chairman of the Board
- Robert Yolles
- President, Chief Executive Officer, Director
- Joel Bernstein
- President, Chief Executive Officer
- Jeffrey Bernstein
- Chief Financial Officer, Vice President, Secretary
- David Starr
- Senior Vice President - Scientific Affairs, Director
- Scott Phillips
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $80.00 |
|---|---|
Revenue (TTM) | $1.4M |
Shares Outstanding | 77.4M |
Winston Pharmaceuticals Inc does not pay a dividend. | |
Beta | --- |
EPS | $-0.04 |
Book Value | $0.01 |
P/E Ratio | 0.0x |
Price/Sales (TTM) | 0.0 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -176.09% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
